These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12079295)

  • 21. Specific keynote: chemoprevention of ovarian cancer: the journey begins.
    Ozols RF; Daly MB; Klein-Szanto A; Hamilton TC; Bast RC; Brewer MA
    Gynecol Oncol; 2003 Jan; 88(1 Pt 2):S59-66; discussion S67-70. PubMed ID: 12586088
    [No Abstract]   [Full Text] [Related]  

  • 22. Fenretinide in the prevention of breast cancer in premenopausal women: fluke or fact?
    Pritchard KI
    Ann Oncol; 2006 Jul; 17(7):1035-6. PubMed ID: 16766581
    [No Abstract]   [Full Text] [Related]  

  • 23. Synthetic retinoid fenretinide in breast cancer chemoprevention.
    Bonanni B; Lazzeroni M; Veronesi U
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):423-32. PubMed ID: 17428163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re: Vitamin A analogue for breast cancer prevention: a grade of F or incomplete?
    Veronesi U; De Palo G; Marubini E; Costa A; Mariani L; Formelli F; Decensi A
    J Natl Cancer Inst; 2000 Feb; 92(3):274; author reply 274-5. PubMed ID: 10655447
    [No Abstract]   [Full Text] [Related]  

  • 25. Preliminary results on safety and activity of a randomized, double-blind, 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal women.
    Guerrieri-Gonzaga A; Robertson C; Bonanni B; Serrano D; Cazzaniga M; Mora S; Gulisano M; Johansson H; Formelli F; Intra M; Latronico A; Franchi D; Pelosi G; Johnson K; Decensi A
    J Clin Oncol; 2006 Jan; 24(1):129-35. PubMed ID: 16382122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemoprevention trial of contralateral breast cancer with fenretinide. Rationale, design, methodology, organization, data management, statistics and accrual.
    De Palo G; Camerini T; Marubini E; Costa A; Formelli F; Del Vecchio M; Mariani L; Miceli R; Mascotti G; Magni A; Campa T; Di Mauro MG; Attili A; Maltoni C; Del Turco MR; Decensi A; D'Aiuto G; Veronesi U
    Tumori; 1997; 83(6):884-94. PubMed ID: 9526578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re: Vitamin A analogue for breast cancer prevention: a grade of F or incomplete?
    Meyskens FL
    J Natl Cancer Inst; 2000 Feb; 92(3):274-5. PubMed ID: 10655448
    [No Abstract]   [Full Text] [Related]  

  • 28. Time course of fenretinide-induced modulation of circulating insulin-like growth factor (IGF)-i, IGF-II and IGFBP-3 in a bladder cancer chemoprevention trial.
    Torrisi R; Mezzetti M; Johansson H; Barreca A; Pigatto F; Robertson C; Decensi A
    Int J Cancer; 2000 Aug; 87(4):601-5. PubMed ID: 10918204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fenretinide: a prototype cancer prevention drug.
    Malone W; Perloff M; Crowell J; Sigman C; Higley H
    Expert Opin Investig Drugs; 2003 Nov; 12(11):1829-42. PubMed ID: 14585058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemoprevention of breast cancer with fenretinide (4-HPR): study of long-term visual and ophthalmologic tolerability.
    Mariani L; Formelli F; De Palo G; Manzari A; Camerini T; Campa T; Di Mauro MG; Crippa A; Delle Grottaglie M; Del Vecchio M; Marubini E; Costa A; Veronesi U
    Tumori; 1996; 82(5):444-9. PubMed ID: 9063520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoprevention of breast cancer with fenretinide.
    Torrisi R; Decensi A; Formelli F; Camerini T; De Palo G
    Drugs; 2001; 61(7):909-18. PubMed ID: 11434448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between plasma transforming growth factor-beta 1 and second primary breast cancer in a chemoprevention trial.
    Decensi A; Torrisi R; Fontana V; Barreca A; Ponzani P; Pensa F; Parodi S; Costa A
    Eur J Cancer; 1998 Jun; 34(7):999-1003. PubMed ID: 9849446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [-Results of ongoing breast cancer prevention studies-].
    Jungi WF
    Arch Gynecol Obstet; 1995; 256 Suppl():S116-21. PubMed ID: 8619644
    [No Abstract]   [Full Text] [Related]  

  • 34. Quality control for HPLC assay and surrogate end point biomarkers from the fenretinide (4-HPR) breast cancer prevention trial.
    Formelli F
    J Cell Biochem Suppl; 2000; 34():73-9. PubMed ID: 10762018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retinoids for ovarian cancer prevention: laboratory data set the stage for thoughtful clinical trials.
    Veronesi U; Decensi A
    J Natl Cancer Inst; 2001 Apr; 93(7):486-8. PubMed ID: 11287432
    [No Abstract]   [Full Text] [Related]  

  • 36. Surrogate response biomarkers in prevention research: do they point the way or lead us astray?
    Fabian CJ
    J Clin Oncol; 2009 Aug; 27(23):3734-6. PubMed ID: 19597020
    [No Abstract]   [Full Text] [Related]  

  • 37. Randomized trial of fenretinide (4-HPR) to prevent recurrences, new localizations and carcinomas in patients operated on for oral leukoplakia: long-term results.
    Chiesa F; Tradati N; Grigolato R; Boracchi P; Biganzoli E; Crose N; Cavadini E; Formelli F; Costa L; Giardini R; Zurrida S; Costa A; De Palo G; Veronesi U
    Int J Cancer; 2005 Jul; 115(4):625-9. PubMed ID: 15700313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras+myc-induced carcinomas in the mouse prostate reconstitution model system.
    Slawin K; Kadmon D; Park SH; Scardino PT; Anzano M; Sporn MB; Thompson TC
    Cancer Res; 1993 Oct; 53(19):4461-5. PubMed ID: 8402613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can fenretinide protect women against ovarian cancer?
    De Palo G; Veronesi U; Camerini T; Formelli F; Mascotti G; Boni C; Fosser V; Del Vecchio M; Campa T; Costa A
    J Natl Cancer Inst; 1995 Jan; 87(2):146-7. PubMed ID: 7707390
    [No Abstract]   [Full Text] [Related]  

  • 40. [Breakthrough in breast cancer chemoprevention].
    Kahán Z; Thurzó L
    Orv Hetil; 2003 Mar; 144(13):597-603. PubMed ID: 12728784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.